Symbotic Inc. (NYSE:SYM) will release earnings results for the fourth quarter, after the closing bell on Monday, Nov. 24.
Analysts expect the Wilmington, Massachusetts-based company to report quarterly earnings of 8 cents per share, down from 47 cents per share in the year-ago period. The consensus estimate for Symbiotic’s quarterly revenue is $604 million. Benzinga Pro data shows $576.77 million in quarterly revenue a year ago.
On Aug. 6, Symbiotic reported a third-quarter EPS miss and issued fourth-quarter sales guidance below estimates.
Shares of Symbotic gained 1.4% to close at $54.72 on Thursday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
- UBS analyst Damian Karas downgraded the stock from Neutral to Sell and raised the price target from $27 to $35 on Sept. 23, 2025. This analyst has an accuracy rate of 60%.
- DA Davidson analyst Matt Summerville downgraded the stock from Buy to Neutral and raised the price target from $35 to $47 on Aug. 25, 2025. This analyst has an accuracy rate of 73%.
- Needham analyst James Ricchiuti maintained a Buy rating and raised the price target from $32 to $57 on Aug. 7, 2025. This analyst has an accuracy rate of 79%.
- Oppenheimer analyst Colin Rusch maintained an Outperform rating and increased the price target from $54 to $59 on Aug. 7, 2025. This analyst has an accuracy rate of 64%.
- Northland Capital Market analyst Michael Latimore maintained an Outperform rating and raised the price target from $35 to $56 on July 8, 2025. This analyst has an accuracy rate of 63%
Considering buying SYM stock? Here’s what analysts think:
Read This Next:
- How To Earn $500 A Month From Woodward Stock Ahead Of Q4 Earnings
Photo via Shutterstock